- Home
- PRPO vs PBM Comparison
PRPO vs PBM Comparison
Compare PRPO & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- PBM
- Stock Information
- Founded
- PRPO N/A
- PBM 1994
- Country
- PRPO United States
- PBM Canada
- Employees
- PRPO N/A
- PBM N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- PBM
- Sector
- PRPO Industrials
- PBM
- Exchange
- PRPO Nasdaq
- PBM NYSE
- Market Cap
- PRPO 8.8M
- PBM 7.5M
- IPO Year
- PRPO N/A
- PBM N/A
- Fundamental
- Price
- PRPO $6.51
- PBM $1.79
- Analyst Decision
- PRPO
- PBM
- Analyst Count
- PRPO 0
- PBM 0
- Target Price
- PRPO N/A
- PBM N/A
- AVG Volume (30 Days)
- PRPO 8.3K
- PBM 5.4M
- Earning Date
- PRPO 11-06-2024
- PBM 02-02-2025
- Dividend Yield
- PRPO N/A
- PBM N/A
- EPS Growth
- PRPO N/A
- PBM N/A
- EPS
- PRPO N/A
- PBM N/A
- Revenue
- PRPO $17,411,000.00
- PBM N/A
- Revenue This Year
- PRPO $75.18
- PBM N/A
- Revenue Next Year
- PRPO N/A
- PBM N/A
- P/E Ratio
- PRPO N/A
- PBM N/A
- Revenue Growth
- PRPO 31.31
- PBM N/A
- 52 Week Low
- PRPO $4.31
- PBM $1.51
- 52 Week High
- PRPO $7.30
- PBM $593.25
- Technical
- Relative Strength Index (RSI)
- PRPO 64.52
- PBM 39.22
- Support Level
- PRPO $6.00
- PBM $1.61
- Resistance Level
- PRPO $6.34
- PBM $2.25
- Average True Range (ATR)
- PRPO 0.37
- PBM 0.22
- MACD
- PRPO 0.09
- PBM 0.06
- Stochastic Oscillator
- PRPO 100.00
- PBM 23.38
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.